• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

SJG-136 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5755533

MBS5755533 is an inhibitor targeting SJG-136. SJG-136 is a DNA cross-linking agent (XL50: 45nM for pBR322 DNA). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
SJG-136, Inhibitor
Full Product Name
SJG-136
Product Gene Name
Product Synonym Names
NSC-694501
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
556.61
Solubility
DMSO: 100mg/mL (179.66mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C31H32N4O6
SMILES
O=C1N2[C@@H](CC(C2)=C)C=NC3=CC(OCCCOC4=C(OC)C=C(C(N(CC(C5)=C)[C@@H]5C=N6)=O)C6=C4)=C(OC)C=C31
CAS Number
232931-57-6
Target & IC50
pBR322 DNA: ic50 45nM (XL50)
In Vitro
SJG-136-induced H2AX phosphorylation shows good correspondence, but less sensitivity, than measurement of foci. SJG-136 displays a more potent antitumor effect against CMeC-1 tumor at 0.30mg/kg than 0.15mg/kg either as a single dose or administered once a week for three weeks via dosed intravenously in mice [2].

Structure of SJG-136, inhibitor

SJG-136 Inhibitor – Cat# MBS5755533

Product References and Citations for SJG-136, inhibitor

Gregson SJ, et al. Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity. J Med Chem. 2001 Mar 1;44(5):737-48.
Gregson SJ, et al. Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity. J Med Chem. 2001 Mar 1;44(5):737-48.
Mellinas-Gomez M, et al. Activity of the DNA minor groove cross-linking agent SG2000 (SJG-136) against canine tumours. BMC Vet Res. 2015 Aug 19;11:215.
Mellinas-Gomez M, et al. Activity of the DNA minor groove cross-linking agent SG2000 (SJG-136) against canine tumours. BMC Vet Res. 2015 Aug 19;11:215.

Other Notes

Small volumes of SJG-136, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000